Robert R. McMillan, MD, MPH

Assistant Professor of Clinical Surgery, Academic Institute
Assistant Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Publications

Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis
Moreira, AL, Won, HH, McMillan, R, Huang, J, Riely, GJ, Ladanyi, M & Berger, MF 2015, Journal of Thoracic Oncology, vol. 10, no. 2, pp. 373-380. https://doi.org/10.1097/JTO.0000000000000397

Second primary lung cancers: Smokers versus nonsmokers after resection of stage I lung adenocarcinoma
Ripley, RT, McMillan, RR, Sima, CS, Hasan, SM, Ahmad, U, Lou, F, Jones, DR, Rusch, VW, Rizk, NP & Huang, J 2014, , Annals of Thoracic Surgery, vol. 98, no. 3, pp. 968-974. https://doi.org/10.1016/j.athoracsur.2014.04.098

Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes
Moo, TA, McMillan, R, Lee, M, Stempel, M, Ho, A, Patil, S & El-Tamer, M 2014, , Annals of Surgical Oncology, vol. 21, no. 5, pp. 1569-1574. https://doi.org/10.1245/s10434-014-3488-x

Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations
Zauderer, MG, Bott, M, Mcmillan, R, Sima, CS, Rusch, V, Krug, LM & Ladanyi, M 2013, , Journal of Thoracic Oncology, vol. 8, no. 11, pp. 1430-1433. https://doi.org/10.1097/JTO.0b013e31829e7ef9

Selection criteria for postmastectomy radiotherapy in T1-T2 tumors with 1 to 3 positive lymph nodes
Moo, TA, McMillan, R, Lee, M, Stempel, M, Patil, S, Ho, A & El-Tamer, M 2013, , Annals of Surgical Oncology, vol. 20, no. 10, pp. 3169-3174. https://doi.org/10.1245/s10434-013-3117-0

Recurrence patterns after resection of soft tissue sarcomas of the chest wall
McMillan, R, Sima, CS, Moraco, NH, Rusch, VW & Huang, J 2013, Annals of Thoracic Surgery, vol. 96, no. 4, pp. 1223-1228. https://doi.org/10.1016/j.athoracsur.2013.05.015

New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment
Ladanyi, M, Zauderer, MG, Krug, LM, Ito, T, McMillan, R, Bott, M & Giancotti, F 2012, , Clinical Cancer Research, vol. 18, no. 17, pp. 4485-4490. https://doi.org/10.1158/1078-0432.CCR-11-2375